{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:51:55Z","timestamp":1794109915807,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Targeted support for high-starting landmark achievements of Zhejiang Chinese Medical University","award":["GQD24SH48"],"award-info":[{"award-number":["GQD24SH48"]}]},{"name":"Targeted support for high-starting landmark achievements of Zhejiang Chinese Medical University","award":["GQD24SH47"],"award-info":[{"award-number":["GQD24SH47"]}]},{"name":"Leading Talents + X Program of Zhejiang Province","award":["2025C02174"],"award-info":[{"award-number":["2025C02174"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01964-3","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:26:19Z","timestamp":1766147179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel DNA methylation biomarkers in urine for non-invasive diagnosis of bladder urothelial carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Cong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"3","key":"1964_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1964_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, et al. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"1964_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","volume":"20","author":"M Maas","year":"2023","unstructured":"Maas M, Todenh\u00f6fer T, Black PC. Urine biomarkers in bladder cancer \u2014 current status and future perspectives. Nat Rev Urol. 2023;20(10):597\u2013614.","journal-title":"Nat Rev Urol"},{"key":"1964_CR4","doi-asserted-by":"crossref","unstructured":"Kanwal R, Gupta K, and Gupta S, Cancer epigenetics: an introduction. Methods in molecular biology (Clifton, N.J.), 2015. 1238:3\u201325.","DOI":"10.1007\/978-1-4939-1804-1_1"},{"issue":"2","key":"1964_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","volume":"6","author":"D Roy","year":"2020","unstructured":"Roy D, Tiirikainen M. Diagnostic power of DNA methylation classifiers for early detection of cancer. Trends Cancer. 2020;6(2):78\u201381.","journal-title":"Trends Cancer"},{"issue":"12","key":"1964_CR6","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1172\/JCI139597","volume":"130","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang J, Ruan W, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Invest. 2020;130(12):6278\u201389.","journal-title":"J Clin Invest"},{"issue":"2","key":"1964_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14737159.2020.1699791","volume":"20","author":"A Lopez-Beltran","year":"2020","unstructured":"Lopez-Beltran A, Cheng L, Gevaert T, et al. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Rev Mol Diagn. 2020;20(2):231\u201343.","journal-title":"Expert Rev Mol Diagn"},{"key":"1964_CR8","doi-asserted-by":"crossref","unstructured":"van Kessel K E M, Beukers W, Lurkin I, et al. 2017. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy. Journal of Urology. 197(3P1):590-595.","DOI":"10.1016\/j.juro.2016.09.118"},{"issue":"1","key":"1964_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13148-021-01029-1","volume":"13","author":"P Piatti","year":"2021","unstructured":"Piatti P, Chew YC, Suwoto M, et al. Clinical evaluation of bladder CARE, a new epigenetic test for bladder cancer detection in urine samples. Clin Epigenetics. 2021;13(1):84.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"1964_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","volume":"1","author":"JA Witjes","year":"2018","unstructured":"Witjes JA, Morote J, Cornel EB, et al. Performance of the bladder epicheck\u2122 methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective. Blinded Clin Trial European Urol Oncol. 2018;1(4):307\u201313.","journal-title":"Blinded Clin Trial European Urol Oncol"},{"issue":"1","key":"1964_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-024-01974-4","volume":"23","author":"J Wu","year":"2024","unstructured":"Wu J, Lin Y, Yang K, et al. Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial. Mol Cancer. 2024;23(1):57.","journal-title":"Mol Cancer"},{"issue":"1","key":"1964_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13148-021-01073-x","volume":"13","author":"W Ruan","year":"2021","unstructured":"Ruan W, Chen X, Huang M, et al. A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer. Clin Epigenetics. 2021;13(1):91.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"1964_CR13","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.18632\/oncotarget.6666","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yu Y, Ye R, et al. An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese. Oncotarget. 2016;7(3):2754\u201364.","journal-title":"Oncotarget"},{"issue":"1","key":"1964_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12885-022-09268-y","volume":"22","author":"Q Fang","year":"2022","unstructured":"Fang Q, Zhang X, Nie Q, et al. Improved urine DNA methylation panel for early bladder cancer detection. BMC Cancer. 2022;22(1):237.","journal-title":"BMC Cancer"},{"issue":"7","key":"1964_CR15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1158\/1078-0432.CCR-13-2637","volume":"20","author":"S-F Su","year":"2014","unstructured":"Su S-F, de Castro Abreu AL, Chihara Y, et al. A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence. Clin Cancer Res. 2014;20(7):1978\u201389.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1964_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3233\/CBM-160261","volume":"18","author":"JJ Fantony","year":"2017","unstructured":"Fantony JJ, Longo TA, Gopalakrishna A, et al. Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer. Cancer Biomark. 2017;18(4):381\u20137.","journal-title":"Cancer Biomark"},{"issue":"1","key":"1964_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejca.2013.08.025","volume":"50","author":"S Monteiro-Reis","year":"2014","unstructured":"Monteiro-Reis S, Le\u00e7a L, Almeida M, et al. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation. Eur J Cancer. 2014;50(1):226\u201333.","journal-title":"Eur J Cancer"},{"issue":"11","key":"1964_CR18","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148\u201359.","journal-title":"N Engl J Med"},{"issue":"1","key":"1964_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0022-5347(01)66652-7","volume":"155","author":"ED King","year":"1996","unstructured":"King ED, Matteson J, Jacobs SC, et al. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol. 1996;155(1):316\u201320.","journal-title":"J Urol"},{"key":"1964_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1742-6413-3-28","volume":"3","author":"A Bhatia","year":"2006","unstructured":"Bhatia A, Dey P, Kakkar N, et al. Malignant atypical cell in urine cytology: a diagnostic dilemma. Cytojournal. 2006;3:28.","journal-title":"Cytojournal"},{"issue":"3","key":"1964_CR21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/carcin\/bgr321","volume":"33","author":"C Yu","year":"2012","unstructured":"Yu C, Zhang Z, Liao W, et al. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK\/ERK signaling pathway. Carcinogenesis. 2012;33(3):678\u201386.","journal-title":"Carcinogenesis"},{"issue":"5","key":"1964_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04947-x","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Xiong L, Wu Z, et al. Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via transcriptional repression of MDR1. Cell Death Dis. 2022;13(5):492.","journal-title":"Cell Death Dis"},{"key":"1964_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-14-28","volume":"14","author":"L Qu","year":"2014","unstructured":"Qu L, Deng B, Zeng Y, et al. Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer. Cancer Cell Int. 2014;14:28.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"1964_CR24","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.gendis.2022.10.001","volume":"10","author":"C Mio","year":"2023","unstructured":"Mio C, Baldan F, Damante G. NK2 homeobox gene cluster: functions and roles in human diseases. Genes Dis. 2023;10(5):2038\u201348.","journal-title":"Genes Dis"},{"issue":"13","key":"1964_CR25","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/cncr.25818","volume":"117","author":"A Bell","year":"2011","unstructured":"Bell A, Bell D, Weber RS, et al. Cpg island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer. 2011;117(13):2898\u2013909.","journal-title":"Cancer"},{"key":"1964_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111434","author":"S Nagel","year":"2021","unstructured":"Nagel S, Pommerenke C, Meyer C, et al. NKL homeobox genes NKX2-3 and NKX2-4 deregulate megakaryocytic-erythroid cell differentiation in AML. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222111434.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1964_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1631\/jzus.B1100382","volume":"13","author":"L Yang","year":"2012","unstructured":"Yang L, Lin M, Ruan WJ, et al. Nkx2-1: a novel tumor biomarker of lung cancer. J Zhejiang Univ Sci B. 2012;13(11):855\u201366.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"7345","key":"1964_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature09881","volume":"473","author":"MM Winslow","year":"2011","unstructured":"Winslow MM, Dayton TL, Verhaak RG, et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 2011;473(7345):101\u20134.","journal-title":"Nature"},{"key":"1964_CR29","doi-asserted-by":"publisher","first-page":"8862821","DOI":"10.1155\/2021\/8862821","volume":"2021","author":"F Xiang","year":"2021","unstructured":"Xiang F, Li L, Lin J, et al. Network pharmacology and bioinformatics methods reveal the mechanism of Zao-Jiao-Ci in the treatment of LSCC. J Oncol. 2021;2021:8862821.","journal-title":"J Oncol"},{"issue":"8","key":"1964_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/gtmb.2021.0066","volume":"25","author":"H Guo","year":"2021","unstructured":"Guo H, Li C, Su X, et al. A five-mRNA expression signature to predict survival in oral squamous cell carcinoma by integrated bioinformatic analyses. Genet Test Mol Biomarkers. 2021;25(8):517\u201327.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1964_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2024.112383","volume":"594","author":"LC Veronez","year":"2024","unstructured":"Veronez LC, Xavier AET, Nagano LF, et al. Identifying prognostic hub genes and key pathways in pediatric adrenocortical tumors through RNA sequencing and co-expression analysis. Mol Cell Endocrinol. 2024;594:112383.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"1964_CR32","first-page":"4361","volume":"16","author":"T Xu","year":"2018","unstructured":"Xu T, Li D, He Y, et al. The expression level of CSDAP1 in lung cancer and its clinical significance. Oncol Lett. 2018;16(4):4361\u20136.","journal-title":"Oncol Lett"},{"issue":"4","key":"1964_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094023","volume":"9","author":"E Andersson","year":"2014","unstructured":"Andersson E, Steven K, Guldberg P. Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer. PLoS ONE. 2014;9(4):e94023.","journal-title":"PLoS ONE"},{"issue":"15","key":"1964_CR34","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1016\/j.ejca.2013.04.033","volume":"49","author":"M Birkhahn","year":"2013","unstructured":"Birkhahn M, Mitra AP, Williams AJ, et al. A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. Eur J Cancer. 2013;49(15):3159\u201368.","journal-title":"Eur J Cancer"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01964-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01964-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01964-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:26:21Z","timestamp":1766147181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-025-01964-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01964-3","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University. Written informed consent was gained from all participants based on the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}